Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Protecting Access to Medicare Act of 2014: Will price reporting rule drive small labs out of business?

Other problems include lack of time for clinical laboratories to get required data to CMS

This first assessment of the PAMA (Protecting Access to Medicare Act of 2014) proposed rule on market reporting of lab prices gives pathologists and lab executives insights about the good, the bad, and the ugly in the language of the proposed rule. One lab group representing independent and community lab companies says that the proposed …

Protecting Access to Medicare Act of 2014: Will price reporting rule drive small labs out of business? Read More »

To access this post, you must purchase The Dark Report.

Comments

;